1 completed, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Unknown 1 |
Follow Chronic Liver Disease Foundation: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD) Ribavirin, Peginterferon, Boceprevir - Chronic Hepatitis C, End Stage Renal Disease | Phase 4 | Unknown | Liver Institute of Virginia | 20 | 2013-01-01 | 2012-11-22 |
| Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy Educational Intervention, Patient education and management skills training - Chronic Hepatitis C, Genotype 1 | Phase 4 | Completed | Chronic Liver Disease Foundation | 197 | 2011-12-01 | 2015-01-06 |
Hepatitis C, Chronic (2) · Kidney Failure, Chronic (1)
N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide (2) · Ribavirin (2) · peginterferon alfa-2b (2) · Early Intervention, Educational (1) · Patient Education as Topic (1) · peginterferon alfa-2a (1)
United States (2)
Fred Poordad, MD (1) · Mitchell L Shiffman, MD (1)